Summary
The product BPC-157 underwent independent testing for concentration and purity. Submitted by acepharmaadmin@protonmail.com, the sample analysis was conducted by Janoshik Analytical. The measured concentration was 4.57 mg with a purity of 97.774%.
Testing was initiated on 5 July 2024, with the sample received on 18 July 2024. The analysis was completed on the same day, 18 July 2024.
Detailed Report
Product Overview
- Manufacturer: Unknown
- Product Name: BPC-157
- Active Ingredient: BPC-157
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #45523
- Testing Ordered: 5 July 2024
- Sample Received: 18 July 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: ACE Pharmaceuticals (Manufacturer)
- Analysis Paid For By: ACE Pharmaceuticals (Manufacturer)
Testing Results
- Label Specification: Not provided
- Measured Concentration: 4.57 mg
- Purity: 97.774%
- Variance: 91.40%
Verification Details
- Verification URL: https://janoshik.com/tests/45523_M3FRN4KEYZ89
Evaluation of Manufacturer-Submitted Testing
The product demonstrates a high purity level of 97.774%, although slightly lower compared to other high-purity peptide products. The measured concentration of 4.57 mg aligns with expected dosage requirements, though no label claim was provided for verification.
Conclusion
The product exhibits high purity and consistent dosage, suggesting a well-formulated peptide. However, independent third-party testing is recommended for comprehensive quality assurance.
Disclaimer
This report is for educational purposes and highlights findings based on manufacturer-submitted testing. Independent third-party testing is advised for comprehensive validation.
